Divya Gupta Selected Research

niraparib

7/2022	Niraparib treatment for patients with BRCA-mutated ovarian cancer: review of clinical data and therapeutic context.
1/2022	OVARIO phase II trial of combination niraparib plus bevacizumab maintenance therapy in advanced ovarian cancer following first-line platinum-based chemotherapy with bevacizumab.
1/2022	Efficacy of niraparib by time of surgery and postoperative residual disease status: A post hoc analysis of patients in the PRIMA/ENGOT-OV26/GOG-3012 study.
11/2021	Pharmacokinetics and safety of niraparib in patients with moderate hepatic impairment.
12/2019	Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Divya Gupta Research Topics

Disease

19	Neoplasms (Cancer) 05/2022 - 12/2006
14	Heart Failure 01/2022 - 07/2012
9	Ovarian Neoplasms (Ovarian Cancer) 07/2022 - 09/2008
6	COVID-19 01/2022 - 12/2020
5	Infections 01/2022 - 12/2017
4	Inflammation (Inflammations) 08/2021 - 09/2012
4	Carcinoma (Carcinomatosis) 01/2016 - 04/2011
4	Endometrial Neoplasms (Endometrial Cancer) 11/2015 - 12/2006
3	Weight Loss (Weight Reduction) 03/2017 - 01/2016
2	Ovarian Epithelial Carcinoma 07/2022 - 06/2009
2	Wounds and Injuries (Trauma) 06/2022 - 04/2021
2	Thrombocytopenia (Thrombopenia) 01/2022 - 11/2021
2	Fatigue 01/2022 - 01/2018
2	Edema (Dropsy) 12/2021 - 01/2015
2	Postoperative Pain 04/2021 - 07/2020
2	Pain (Aches) 04/2021 - 01/2015
2	Myocardial Infarction 01/2021 - 01/2006
2	Neoplasm Metastasis (Metastasis) 01/2021 - 11/2013
2	Stroke (Strokes) 01/2021 - 12/2015
2	Disease Progression 12/2019 - 03/2017
2	Cough 01/2019 - 04/2014
2	Obstructive Sleep Apnea 01/2018 - 08/2015
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 12/2017 - 10/2016
2	Dyspnea (Shortness of Breath) 03/2017 - 03/2017
2	Ischemia 01/2017 - 06/2010
2	Macular Degeneration (Age-Related Maculopathy) 09/2016 - 08/2014
2	Carcinosarcoma 01/2016 - 11/2015
2	Endometrioid Carcinoma 01/2016 - 12/2006
2	Uterine Neoplasms (Uterine Cancer) 09/2014 - 06/2009
1	Fallopian Tube Neoplasms 01/2022
1	Hyperkalemia 01/2022
1	Hoarseness 01/2022
1	Anemia 01/2022
1	Epidermolysis Bullosa Simplex (Epidermolysis Bullosa Herpetiformis Dowling Meara) 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Muscular Dystrophies (Muscular Dystrophy) 01/2022
1	Arthritis (Polyarthritis) 12/2021
1	Vesicular Stomatitis 10/2021
1	Virus Diseases (Viral Diseases) 10/2021
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 10/2021
1	Neuromuscular Diseases (Neuromuscular Disease) 09/2021
1	Chemical and Drug Induced Liver Injury 08/2021

Drug/Important Bio-Agent (IBA)

5	niraparibIBA 07/2022 - 12/2019
5	PlatinumIBA 01/2022 - 06/2009
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2011
5	Pharmaceutical PreparationsIBA 09/2021 - 09/2008
4	DiureticsIBA 07/2018 - 04/2015
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2020 - 06/2013
3	Anti-Bacterial Agents (Antibiotics)IBA 12/2017 - 08/2011
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2016 - 06/2010
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2022 - 10/2021
2	Viral RNAIBA 01/2022 - 10/2021
2	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2022 - 10/2020
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 12/2021
2	VaccinesIBA 11/2021 - 01/2012
2	Antiviral Agents (Antivirals)IBA 10/2021 - 01/2020
2	Methotrexate (Mexate)FDA LinkGeneric 08/2021 - 10/2019
2	Clonidine (ST 155)FDA LinkGeneric 04/2021 - 07/2020
2	Angiotensin Receptor AntagonistsIBA 10/2020 - 04/2015
2	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 07/2018 - 01/2016
2	Inosine Triphosphate (ITP)IBA 12/2017 - 10/2016
2	AutoantibodiesIBA 12/2017 - 10/2016
2	Tolvaptan FDA Link 03/2017 - 03/2017
2	A 7 (A-7)IBA 03/2017 - 07/2011
2	SteroidsIBA 12/2016 - 01/2015
2	Hydralazine (Apresoline)FDA LinkGeneric 10/2014 - 06/2013
2	NitratesIBA 10/2014 - 06/2013
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 07/2022
1	Vasoconstrictor AgentsIBA 06/2022
1	Serotonin (5 Hydroxytryptamine)IBA 06/2022
1	Epinephrine (Adrenaline)FDA LinkGeneric 06/2022
1	Neurotransmitter Agents (Neurotransmitter)IBA 06/2022
1	Dopamine (Intropin)FDA LinkGeneric 06/2022
1	NeuropeptidesIBA 06/2022
1	Discoidin Domain Receptor 2IBA 05/2022
1	C-Reactive ProteinIBA 01/2022
1	PlectinIBA 01/2022
1	Neutralizing AntibodiesIBA 01/2022
1	Ferritins (Ferritin)IBA 01/2022
1	pro-brain natriuretic peptide (1-76)IBA 01/2022
1	Valsartan (Vals)FDA Link 01/2022
1	Bevacizumab (Avastin)FDA Link 01/2022
1	Analgesics (Analgesic Drugs)IBA 12/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 11/2021
1	Immune Sera (Antisera)IBA 11/2021
1	Pattern Recognition ReceptorsIBA 10/2021
1	Transcription Factors (Transcription Factor)IBA 10/2021
1	glabridinIBA 08/2021
1	Saline SolutionIBA 04/2021

Therapy/Procedure

17	Therapeutics 01/2022 - 12/2006
8	Drug Therapy (Chemotherapy) 01/2022 - 06/2009
4	Radiotherapy 01/2016 - 11/2013
3	Continuous Positive Airway Pressure 01/2018 - 08/2015
3	Hysterectomy 01/2016 - 02/2013
3	Brachytherapy 01/2016 - 11/2013
2	Heart-Assist Devices 01/2022 - 12/2015
2	Anesthesia 07/2020 - 04/2014
2	Critical Care (Surgical Intensive Care) 03/2020 - 10/2019
2	Lasers (Laser) 01/2017 - 05/2016
1	Oral Administration 08/2021